Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -2.86% is 96% above its 5-year average of -77.10%, near the high end of its 5-year range (-168.71%–-2.86%).
As of the fiscal period ended Tuesday, June 30, 2026. 91.52% above its 12-month average of -33.73%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -2.86%.
RETURN ON INVESTED CAPITAL (ROIC)
-2.86%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-33.73%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-70.21%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-77.10%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-52.78%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
-59.57%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+91.52%
CURRENT VS 3Y AVG
+95.92%
CURRENT VS 5Y AVG
+96.29%
CURRENT VS 10Y AVG
+94.58%
CURRENT VS 15Y AVG
+95.20%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-25.26%
median of 375 covered companies
CURRENT VS SECTOR MEDIAN
+88.67%
vs the sector median at left
Assembly Biosciences, Inc.
Market Cap
$450.64M
Return on Invested Capital (ROIC)
-2.86%
TTM Avg
-33.73%
3Y Avg
-70.21%
5Y Avg
-77.10%
Market Cap
$453.70M
Return on Invested Capital (ROIC)
-100.87%
TTM Avg
-63.16%
3Y Avg
-52.79%
5Y Avg
-48.48%
Market Cap
$447.43M
Return on Invested Capital (ROIC)
-40.25%
TTM Avg
-30.86%
3Y Avg
-64.07%
5Y Avg
-59.14%
Market Cap
$468.31M
Return on Invested Capital (ROIC)
8.75%
TTM Avg
20.32%
3Y Avg
26.86%
5Y Avg
29.17%
Market Cap
$471.57M
Return on Invested Capital (ROIC)
-1.08%
TTM Avg
-7.18%
3Y Avg
-14.01%
5Y Avg
-19.76%
Market Cap
$428.16M
Return on Invested Capital (ROIC)
-48.61%
TTM Avg
-80.33%
3Y Avg
-62.04%
5Y Avg
-50.84%
Market Cap
$478.54M
Return on Invested Capital (ROIC)
-27.22%
TTM Avg
-25.30%
3Y Avg
-27.88%
5Y Avg
-30.72%
Market Cap
$481.33M
Return on Invested Capital (ROIC)
-2.19%
TTM Avg
-24.50%
3Y Avg
-28.59%
5Y Avg
-24.45%
Market Cap
$416.68M
Return on Invested Capital (ROIC)
-54.07%
TTM Avg
-33.14%
3Y Avg
-21.50%
5Y Avg
-27.82%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Assembly Biosciences, Inc. (ASMB) | $450.64M | -2.86% | -33.73% | -70.21% | -77.10% |
| DiaMedica Therapeutics Inc. (DMAC)vs › | $453.70M | -100.87% | -63.16% | -52.79% | -48.48% |
| Capricor Therapeutics, Inc. (CAPR)vs › | $447.43M | -40.25% | -30.86% | -64.07% | -59.14% |
| NRC Health (NRC)vs › | $468.31M | 8.75% | 20.32% | 26.86% | 29.17% |
| Cerus Corporation (CERS)vs › | $471.57M | -1.08% | -7.18% | -14.01% | -19.76% |
| Editas Medicine, Inc. (EDIT)vs › | $428.16M | -48.61% | -80.33% | -62.04% | -50.84% |
| Contineum Therapeutics, Inc. (CTNM)vs › | $478.54M | -27.22% | -25.30% | -27.88% | -30.72% |
| Arvinas, Inc. (ARVN)vs › | $481.33M | -2.19% | -24.50% | -28.59% | -24.45% |
| Arcturus Therapeutics Holdings Inc. (ARCT)vs › | $416.68M | -54.07% | -33.14% | -21.50% | -27.82% |
| Carlsmed, Inc. (CARL)vs › | $415.93M | -36.54% | -40.95% | -100.88% | -100.88% |
ROIC
-2.9%
ROE
-0.0%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -2.86% |
| 2026-03-31 | -6.76% |
| 2025-12-31 | -5.80% |
| 2025-09-30 | -23.28% |
| 2025-06-30 | -129.96% |
| 2025-03-31 | -85.20% |
| 2024-12-31 | -63.64% |
| 2024-09-30 | -79.21% |
| 2024-06-30 | -68.24% |
| 2024-03-31 | -68.80% |
| 2023-12-31 | -65.80% |
| 2023-09-30 | -168.71% |
| 2023-06-30 | -144.47% |
| 2023-03-31 | -123.74% |
| 2022-12-31 | -110.08% |
| 2022-09-30 | -126.37% |
| 2022-06-30 | -100.79% |
| 2022-03-31 | -84.59% |
| 2021-12-31 | -75.83% |
| 2021-09-30 | -46.76% |
| 2021-06-30 | -38.10% |
| 2021-03-31 | -24.33% |
| 2020-12-31 | -25.03% |
| 2020-09-30 | -18.59% |
| 2020-06-30 | -27.31% |
| 2020-03-31 | -34.94% |
| 2019-12-31 | -32.56% |
| 2019-09-30 | -49.72% |
| 2019-06-30 | -43.75% |
| 2019-03-31 | -44.61% |
| 2018-12-31 | -37.16% |
| 2018-09-30 | -29.32% |
| 2018-06-30 | -53.04% |
| 2018-03-31 | -38.22% |
| 2017-12-31 | -33.52% |
| 2017-09-30 | -51.77% |
| 2017-06-30 | -46.07% |
| 2017-03-31 | -38.86% |
| 2016-12-31 | -49.76% |
| 2016-09-30 | -40.91% |
| 2016-06-30 | -33.01% |
| 2016-03-31 | -27.90% |
| 2015-12-31 | -22.75% |
| 2015-09-30 | -20.27% |
| 2015-06-30 | -22.25% |
| 2015-03-31 | -19.86% |
| 2014-12-31 | -34.14% |
| 2014-09-30 | -40.05% |
| 2014-06-30 | -86.98% |
| 2014-03-31 | -88.88% |
| 2013-12-31 | -80.04% |
| 2013-09-30 | -57.67% |
| 2013-06-30 | -57.14% |
| 2013-03-31 | -58.17% |
| 2012-12-31 | -139.56% |
| 2012-09-30 | -190.14% |
| 2012-06-30 | -156.54% |
| 2012-03-31 | -143.53% |
| 2011-12-31 | -98.46% |
| 2011-09-30 | -34.98% |
| 2011-06-30 | -122.97% |
| 2011-03-31 | -50.50% |
| 2010-12-31 | -33.76% |
